William R. Larue, Director at Tracon Pharmaceuticals, Inc. (TCON), bought 6,545 shares at $3.82 ($25K) on 2021-07-26, disclosed to the SEC on 2021-07-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CADX | SELL | 2013-12-18 | $78K | — | Filing → |
| CADX | SELL | 2013-11-18 | $263K | — | Filing → |
| CADX | SELL | 2013-07-17 | $65K | — | Filing → |